Insights On Trial Design
-
Transforming CGT With A Synergistic Partnership
1/18/2024
Understand the strategic advantages of a new collaboration and discover how two companies' unified vision promises to elevate CGT to new heights, one empowered patient at a time.
-
Insights Into Candidiasis: Global Clinical Research Overview
2/5/2024
Explore how drug-resistant strains are posing challenges when it comes to the treatment of candidiasis, but therapeutic advancements and ongoing research are offering hope for improved outcomes.
-
The Past, Present, And Future Of Treating Hematological Cancers
6/7/2023
What was once science fiction has moved up to second-line therapy. Read this author's take on navigating the trajectory of how CAR T-Cell Therapy will be used for diffuse large B-cell lymphoma.
-
Trial Control Arms - Best Practices
8/2/2023
Mitchell Katz, SVP, global clinical operations, has “been there, done that,” when it comes to making decisions about trial control arms, which comparator to use, or the number of patients needed in a first-in-class drug development program. Katz shares his process and thinking here.
-
Ulcerative Colitis: The Asia Pacific Clinical Trial Landscape
9/29/2022
Find out how the incidence and prevalence of Ulcerative Colitis in Asia has rapidly increased over the past four decades with an incidence rate of around 6 cases per 100,000 population.
-
Race & Ethnicity In Clinical Trials: Breaking The Status Quo
5/13/2023
By examining the historical lack of diversity in clinical trials, and the impact this has on patient outcomes, the author makes a case for more inclusive trial designs.
-
Elite Learning Series: Solve Clinical Trial Enrollment Struggles With Better Utilization Of Healthcare Data
4/20/2022
This webinar will feature industry leaders from the U.S. Food and Drug Administration (FDA), Freenome, Cerner Enviza, Deep Lens, and Elligo Health Research®. The discussion will also explore potential pitfalls of healthcare data as well as solutions and strategies for overcoming them.
-
A Mid-Sized Sponsor Increased Site Count By 50% In A Rare Disease Clinical Trial
12/8/2022
In this case study, explore how a mid-sized sponsor chose high-performing sites based on reliable data to set their trial up for success.
-
What Keeps Patients From Enrolling In Clinical Trials?
2/1/2023
Explore five key reasons patients may opt not to participate in clinical trials and learn how technology can help overcome patients’ concerns.
-
Demonstrating The Impact Of The Longboat Portal On Recruitment Success
10/13/2022
A top-30 pharmaceutical company was conducting two phase 3, multicentre, randomized, double-blind studies to evaluate the safety and efficacy of a treatment for a serious dermatological condition. So how did the sites involved manage such significant and prolonged engagement?